Suchergebnisse - "cytokine release syndrome"

PubPharm (1.396)

31

MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients : A Phase IIa, Double-Blind, Randomized, Multi-Center Study Comparing MRG-001 to Placebo in Patients With Acute Respiratory Distress Syndrome

enthalten in: ClinicalTrials.gov | 2024

32

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation : A Single-Arm, Open-Label, Pilot Study and Expansion Study of JAK Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

enthalten in: ClinicalTrials.gov | 2024

33

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity : A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

enthalten in: ClinicalTrials.gov | 2024

34

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

enthalten in: Experimental hematology & oncology | 2024

von Wang, L. | Lv, Y. | Zhou, L. | +11

35

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

enthalten in: Experimental hematology & oncology | 2024

von Wang, L. | Lv, Y. | Zhou, L. | +11

36

Cytokine Release Syndrome with Relative Adrenal Insufficiency Induced by Ipilimumab and Nivolumab Combination Therapy for Clear Cell Renal Cell Carcinoma

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Yamamoto, K. | Shiotsu, S. | Sasakura, M. | +6

37

SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors

enthalten in: Cellular & molecular immunology | 2024

von Liang, S. | Zheng, R. | Zuo, B. | +11

38

More about post-transplant cyclophosphamide in haploidentical grafts : full or reduced doses?

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Gallardo-Pérez, M. | Gutiérrez-Aguirre, C. | Olivares-Gazca, J. | +1

39

Perils and Problems in Bispecific T-Cell Engager Antibodies

enthalten in: Current drug safety | 2024

von Khushboo, B. | Kumar, J.

40

Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab : A Case Report

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Shiraishi, Y. | Tokito, T. | Toyozawa, R. | +5